International Chemical Investors Group

International Chemical Investors Group (ICIG) is a privately owned industrial group that specializes in the holding of mid-sized chemicals and pharmaceutical businesses. With over 3,900 employees worldwide, ICIG has sales in excess of €3 billion and operates more than 20 manufacturing plants in various locations, including Belgium, France, Germany, the Netherlands, Poland, Spain, the United Kingdom, and the United States.

ICIG focuses on three main platforms: Fine Chemicals under the WeylChem brand, Chlorovinyls under the VYNOVA brand, and Enterprises, which comprises several specified companies. The company has acquired more than 20 independent chemicals and pharmaceutical businesses in Europe and the United States since its inception in 2004, all of which have origins in major global chemical or pharmaceutical corporations.

The company's operating plants are well-invested in favorable locations with an international orientation and leading positions in niche markets. ICIG values experience and outstanding research and development capabilities in its employees and most of the company's management and employees were well-trained in major corporations.

ICIG's strategy is to leverage its chemicals and pharmaceutical industry experience, combined with operational, transactional, and financing expertise, to develop its operating companies internally or through platform acquisitions and to realize hidden values where others might not. The company offers a range of services, including consulting, financing, research and development, restructuring, management, monitoring, and control services to support its portfolio of companies.

Founded: 2004

Headquarter: Luxembourg City, Luxembourg

Website: https://ic-investors.com/